武田薬品工業株式会社 group: subsidiaries and structure

Summary

武田薬品工業株式会社 is the ultimate parent of 11 subsidiaries with LEIs in 8 countries, as reported to GLEIF. 8 are held directly; the others sit below intermediate companies. The largest numbers are in Austria (3), in the United States (2) and in Belgium (1). 2 of the subsidiaries have a lapsed LEI, and 5 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 33 ISINs for the parent and 0 ISINs for its subsidiaries.

Written from GLEIF data using fixed, reviewed sentence templates.